These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 18833072)

  • 1. Cardiovascular morbidity in psoriasis: epidemiology, pathomechanisms, and clinical consequences.
    Boehncke WH; Boehncke S
    G Ital Dermatol Venereol; 2008 Oct; 143(5):307-13. PubMed ID: 18833072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing comorbidities in psoriasis.
    Boehncke WH; Boehncke S
    Actas Dermosifiliogr; 2009 Dec; 100 Suppl 2():22-7. PubMed ID: 20096158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research in practice: the systemic aspects of psoriasis.
    Boehncke WH; Boehncke S
    J Dtsch Dermatol Ges; 2008 Aug; 6(8):622-5. PubMed ID: 18564207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular health for patients with psoriasis: a précis for front-line clinicians.
    Federman DG; Shelling ML; Prodanovich S; Gunderson CG; Kirsner RS
    Ostomy Wound Manage; 2009 May; 55(5):38-47. PubMed ID: 19471047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular risk factors in high-need psoriasis patients and its implications for biological therapies.
    Driessen RJ; Boezeman JB; Van De Kerkhof PC; De Jong EM
    J Dermatolog Treat; 2009; 20(1):42-7. PubMed ID: 18649164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin and bone: the pathogenetic relationship between psoriasis and psoriatic arthritis.
    Ko JM; Qureshi AW
    G Ital Dermatol Venereol; 2010 Jun; 145(3):393-406. PubMed ID: 20461047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis.
    Alexandroff AB; Pauriah M; Camp RD; Lang CC; Struthers AD; Armstrong DJ
    Br J Dermatol; 2009 Jul; 161(1):1-7. PubMed ID: 19500102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psoriasis: a skin disease associated with increased cardiovascular risk.
    González-Gay MA; González-Vela C; González-Juanatey C
    Actas Dermosifiliogr; 2012 Sep; 103(7):595-8. PubMed ID: 22465257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and metabolic risks in psoriasis and psoriatic arthritis: pragmatic clinical management based on available evidence.
    Johnsson H; McInnes IB; Sattar N
    Ann Rheum Dis; 2012 Apr; 71(4):480-3. PubMed ID: 22294632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study.
    Gisondi P; Tessari G; Conti A; Piaserico S; Schianchi S; Peserico A; Giannetti A; Girolomoni G
    Br J Dermatol; 2007 Jul; 157(1):68-73. PubMed ID: 17553036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The concept of psoriasis as a systemic inflammation: implications for disease management.
    Reich K
    J Eur Acad Dermatol Venereol; 2012 Mar; 26 Suppl 2():3-11. PubMed ID: 22356630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriasis: an opportunity to identify cardiovascular risk.
    Federman DG; Shelling M; Prodanovich S; Gunderson CG; Kirsner RS
    Br J Dermatol; 2009 Jan; 160(1):1-7. PubMed ID: 19016698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review.
    Sterry W; Strober BE; Menter A;
    Br J Dermatol; 2007 Oct; 157(4):649-55. PubMed ID: 17627791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic comorbidities and psoriasis.
    Gisondi P; Ferrazzi A; Girolomoni G
    Acta Dermatovenerol Croat; 2010; 18(4):297-304. PubMed ID: 21251450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 'psoriatic march': a concept of how severe psoriasis may drive cardiovascular comorbidity.
    Boehncke WH; Boehncke S; Tobin AM; Kirby B
    Exp Dermatol; 2011 Apr; 20(4):303-7. PubMed ID: 21410760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular risk and psoriasis: the role of biologic therapy.
    Puig L
    Actas Dermosifiliogr; 2012 Dec; 103(10):853-62. PubMed ID: 23157913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis and cardiovascular disorders.
    Ryan C; Menter A
    G Ital Dermatol Venereol; 2012 Apr; 147(2):179-87. PubMed ID: 22481581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart disease in psoriasis.
    Kremers HM; McEvoy MT; Dann FJ; Gabriel SE
    J Am Acad Dermatol; 2007 Aug; 57(2):347-54. PubMed ID: 17433490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community.
    Menter A; Griffiths CE; Tebbey PW; Horn EJ; Sterry W;
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1371-7. PubMed ID: 20384692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis comorbidities.
    Gottlieb AB; Chao C; Dann F
    J Dermatolog Treat; 2008; 19(1):5-21. PubMed ID: 18273720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.